Search

everythinglearnresearchcommunity

for

Search:↓

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

Skin diseases, especially psoriasis, greatly affect people's quality of life, similar to chronic diseases.

COVID-19 may cause hair loss due to infection stress or treatments.

Home photobiomodulation therapy can improve life quality and mobility for disabled individuals.

The COVID-19 pandemic has led to more severe cases of Leprosy due to delayed medical care.

The letters discussed medical tools, costs, treatment efficacy, and patient care complexities.

Using complex medical terms can make people want to seek medical help faster.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

AI can improve early diagnosis and treatment of diabetic foot complications but requires addressing training and ethical challenges.

High-intensity phototechnology, especially with other treatments, effectively improves quality of life for diffuse alopecia patients.

ChatGPT can be a helpful dermatology resource but should not replace professional consultations.

Dermatology residency programs need better DEI training to improve care for diverse patients.

Patients found AI helpful for alopecia diagnosis but want it to support, not replace, doctors.

HS patients rarely see dermatologists, often get opiates, and need better care.

A 17-year-old girl had severe, on-and-off hair loss, likely due to COVID-19. She was treated with Vitamin D3, biotin, and other supplements, and saw some improvement within a month.

The physical education program improved students' heart and lung health.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

More guidance on evaluating health interventions can improve investment in population health.

The document highlights advancements and findings in dermatology, including AI use, disease prevention, treatment efficacy, and the impact of conditions on patients' lives.

Breast cancer patients need better psychological support to improve their quality of life.

Telogen effluvium negatively affects quality of life, increasing stress, depression, and anxiety.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Dermatology trainees lack standardized guidelines and education for treating testosterone-induced skin conditions in transmasculine individuals.

Integrating lived experiences into health frameworks is crucial for addressing skin diseases and mental health effectively.

The document concludes that forcing doctors to assist in euthanasia against their will is dangerous and goes against democratic values.

Dermatologists greatly affect inpatient diagnosis and treatment of skin conditions, especially in spotting infections in patients with weakened immune systems.

The COVID-19 pandemic has increased hair loss and psychological distress in women.

Combining psychodermatology and PRP therapy can improve skin condition treatment by addressing both mental and physical health.